METASTATIC PANCREATIC NEUROENDOCRINE TUMOR
Clinical trials for METASTATIC PANCREATIC NEUROENDOCRINE TUMOR explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PANCREATIC NEUROENDOCRINE TUMOR trials appear
Sign up with your email to follow new studies for METASTATIC PANCREATIC NEUROENDOCRINE TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental combo targets tough pancreatic tumors
Disease control Recruiting nowThis early-stage study is testing whether combining two drugs—Fulvestrant and a radioactive therapy called Lu-DOTATATE—is safe and might help control advanced pancreatic neuroendocrine tumors. The study will enroll about 25 adults whose cancer has spread and has worsened despite …
Matched conditions: METASTATIC PANCREATIC NEUROENDOCRINE TUMOR
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Apr 01, 2026 18:41 UTC
-
New combo attack on rare pancreatic cancer
Disease control Recruiting nowThis early-stage trial is testing the safety and best dose of combining two targeted cancer drugs for people with advanced pancreatic neuroendocrine tumors (PNETs). One drug blocks signals that help tumors grow, while the other delivers radiation directly to cancer cells. Researc…
Matched conditions: METASTATIC PANCREATIC NEUROENDOCRINE TUMOR
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC